CompoAtlas

Relax Formula with Affron®

Natural health product licensed in Canada

Other names
Stress Relax Formula with Affron®
Licence holder
INutr Health Products Inc.
NPN or DIN-HM
80141680
Status
Active licence
Licence date
9 June 2025
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Crocus sativus

Source : Crocus sativus - Stigmate

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 42 mg

Potency : 3.48 % Crocin

14 mgNot calculated
Crocus sativus

Source : Crocus sativus - Stigmate

Potency : 0.03 % 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde

Not specifiedNot calculated

Non-medicinal ingredients

Dioxyde de titane, Maltodextrine, Hydroxypropyl méthylcellulose, Stéarate de magnésium, Silice

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps in energy metabolism/(and) tissue formation. Helps in the development and maintenance of bones/(and) teeth. Helps to maintain/support normal muscle function, including the heart muscle. Source of/Provides (an) electrolyte(s) for the maintenance of good health. Helps (to) temporarily promote relaxation. Withania somnifera is traditionally used in Ayurveda to help relieve restlessness and/or nervousness which helps to promote sleep. Used in Herbal Medicine as an adaptogen to help increase energy and resistance to stress over time (e.g. in case of mental and physical fatigue related to stress). Affron is clinically shown to relieve restlessness and/or nervousness (calmative). Affron is clinically proven to improve sleep quality in individuals experiencing sleeplessness and clinically shown to help relieve symptoms associated with perimenopause. Affron is clinically proven to support/maintain (healthy) mood balance. Affron is clinically shown to support positive effects on symptoms of perceived stress such as, fatigue, weariness, and irritability. Affron is clinically shown to improve restorative sleep in individuals experiencing sleeplessness. Affron is clinically proven to help improve sleep quality in 4 weeks.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80141680

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line